Skip to main content

Table 3 Longitudinal associations of serum and dialysate electrolytes with QTc interval in 146 incident dialysis patients

From: Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study

Variables

Model 1

Model 2

Model 3

QTc difference (95% CI), ms

P

QTc difference (95% CI), ms

P

QTc difference (95% CI), ms

P

Serum measurements

 Total calcium, per 1 mg/dl decrease

+ 9.13 (0.65, 17.61)

0.04

+ 8.89 (1.20, 16.58)

0.02

+ 7.06 (− 0.59, 14.72)

0.07

 Corrected calcium, per 1 mg/dl decrease

+ 8.29 (−1.29, 17.88)

0.09

+ 7.71 (− 0.91, 16.34)

0.08

+ 5.74 (− 2.78, 14.26)

0.19

 Ionized calciuma, per 0.1 mmol/l decrease

+ 9.79 (3.17, 16.41)

0.004

+ 10.18 (4.02, 16.33)

0.001

+ 9.05 (3.28, 14.83)

0.002

 Potassium, per 1 mEq/l decrease

+ 9.08 (2.23, 15.94)

0.01

+ 9.87 (3.12, 16.62)

0.004

+ 9.43 (2.89, 15.98)

0.01

 Magnesiuma, per 0.1 mEq/l decrease

+ 0.84 (− 1.05, 2.74)

0.38

+ 0.69 (− 1.26, 2.63)

0.49

+ 0.32 (−1.60, 2.24)

0.75

Dialysate measurements

 Calcium

  2.5 mEq/l

reference

 

reference

 

reference

 

  < 2.5 mEq/l

+ 3.18 (− 6.56, 12.91)

0.52

+ 3.03 (− 6.07, 12.14)

0.51

+ 4.00 (− 4.60, 12.60)

0.36

 Potassium

  2 mEq/l

reference

 

reference

 

reference

 

  > 2 mEq/l

− 5.44 (− 21.22, 10.35)

0.50

−6.36 (− 21.05, 8.32)

0.40

− 5.58 (− 19.98, 8.82)

0.45

Serum-to-dialysate gradients

 Total calcium, per 1 mEq/l increase in difference

− 11.13 (− 23.59, 1.33)

0.08

−10.81 (− 22.38, 0.76)

0.07

−8.06 (− 18.88, 2.77)

0.15

 Corrected calcium, per 1 mEq/l increase in difference

− 9.14 (− 22.83, 4.54)

0.19

− 8.48 (− 21.15, 4.19)

0.2

− 5.61 (− 17.34, 6.12)

0.35

  1. Model 1 includes the main exposure (one of serum, dialysate, or gradient measurements)
  2. Model 2 includes model 1, age, sex, and ethnicity
  3. Model 3 includes model 2, Charlson comorbidity index, non-dialysis systolic blood pressure, left ventricular mass index, and use of antihypertensive medication, renin-angiotensin-aldosterone system blockade, cinacalcet, and QT-prolonging medication
  4. aModels with ionized calcium and magnesium also include serum pH